Neue Substanzen in der Therapie des Mammakarzinoms
Crossref DOI link: https://doi.org/10.1007/s00129-017-4085-4
Published Online: 2017-06-07
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schem, C.
Maass, N.
Elessawy, M.
van Mackelenbergh, M.
Heilmann, T.
License valid from 2017-06-07